Common Antihistamines Show Potential in COVID-19 Treatment: A Breakthrough in Cell Testing

Recent research reveals that hydroxyzine, diphenhydramine, and azelastine, commonly used antihistamines, may prevent COVID-19 infection in lab cells. These findings, needing clinical trials, could mark a significant step in the fight against the pandemic.

Read More